147 related articles for article (PubMed ID: 25297850)
1. Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma.
Ramani P; Nash R; Rogers CA
Histopathology; 2015 Feb; 66(3):370-9. PubMed ID: 25297850
[TBL] [Abstract][Full Text] [Related]
2. High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas.
Ramani P; Sowa-Avugrah E; May MT
Virchows Arch; 2015 Sep; 467(3):319-27. PubMed ID: 26199132
[TBL] [Abstract][Full Text] [Related]
3. High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas.
Ramani P; Nash R; Sowa-Avugrah E; Rogers C
J Neurooncol; 2015 Oct; 125(1):103-11. PubMed ID: 26318737
[TBL] [Abstract][Full Text] [Related]
4. High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas.
Ramani P; Taylor S; Miller E; Sowa-Avugrah E; May MT
J Histochem Cytochem; 2015 Jun; 63(6):397-407. PubMed ID: 25711230
[TBL] [Abstract][Full Text] [Related]
5. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
[TBL] [Abstract][Full Text] [Related]
7. Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases.
Tökés AM; Szász AM; Geszti F; Lukács LV; Kenessey I; Turányi E; Meggyesházi N; Molnár IA; Fillinger J; Soltész I; Bálint K; Hanzély Z; Arató G; Szendröi M; Kulka J
J Clin Pathol; 2015 Apr; 68(4):274-82. PubMed ID: 25595275
[TBL] [Abstract][Full Text] [Related]
8. MIB-1 Index as a Surrogate for Mitosis-Karyorrhexis Index in Neuroblastoma.
Atikankul T; Atikankul Y; Santisukwongchote S; Marrano P; Shuangshoti S; Thorner PS
Am J Surg Pathol; 2015 Aug; 39(8):1054-60. PubMed ID: 26171918
[TBL] [Abstract][Full Text] [Related]
9. Proliferation index revisited in neuroblastic tumors.
Iżycka-Świeszewska E; Lipska-Ziętkiewicz BS; Adamkiewicz-Drożyńska E; Grajkowska W; Hermann B; Bień E; Limon J
Folia Neuropathol; 2014; 52(3):243-52. PubMed ID: 25310735
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas.
Dungwa JV; Hunt LP; Ramani P
Histopathology; 2012 Sep; 61(3):417-27. PubMed ID: 22571395
[TBL] [Abstract][Full Text] [Related]
11. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
[TBL] [Abstract][Full Text] [Related]
12. Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.
Dahlhaus M; Burkovski A; Hertwig F; Mussel C; Volland R; Fischer M; Debatin KM; Kestler HA; Beltinger C
Cancer Lett; 2016 Feb; 371(1):79-89. PubMed ID: 26616283
[TBL] [Abstract][Full Text] [Related]
13. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility.
Ekholm M; Beglerbegovic S; Grabau D; Lövgren K; Malmström P; Hartman L; Fernö M
Histopathology; 2014 Aug; 65(2):252-60. PubMed ID: 24527721
[TBL] [Abstract][Full Text] [Related]
15. Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.
Ali HR; Dawson SJ; Blows FM; Provenzano E; Pharoah PD; Caldas C
Br J Cancer; 2012 May; 106(11):1798-806. PubMed ID: 22538974
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the Ki67 scoring categories in breast cancer subgroups.
Niikura N; Masuda S; Kumaki N; Xiaoyan T; Terada M; Terao M; Iwamoto T; Oshitanai R; Morioka T; Tuda B; Okamura T; Saito Y; Suzuki Y; Tokuda Y
Clin Breast Cancer; 2014 Oct; 14(5):323-329.e3. PubMed ID: 24492237
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.
Mejía C; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
Oncol Rep; 2003; 10(1):243-7. PubMed ID: 12469176
[TBL] [Abstract][Full Text] [Related]
19. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
20. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
